CONTEXT THERAPEUTICS INC (CNTX) Stock Income Statement
NASDAQ:CNTX - Nasdaq - US21077P1084 - Common Stock - Currency: USD
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 38.30M | 29.92M | 25.07M | 15.38M | 10.53M | |||
| Research and Development | 30.64M | 22.70M | 17.78M | 7.59M | 6.89M | |||
| Selling, General, and Administrative Expenses | 7.66M | 7.22M | 7.29M | 7.79M | 3.63M | |||
| Operating Income | -38.30M | -29.92M | -25.07M | -15.38M | -10.53M | |||
| Interest Income/Expense | 4.07M | 3.20M | 1.16M | 550.00K | -50.00K | |||
| Other Income/Expense | 21.80K | -1.40K | -55.60K | 0.00 | 20.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | 100.00K | |||
| Income Before Taxes | -34.21M | -26.73M | -23.96M | -14.84M | -10.46M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -34.21M | -26.73M | -23.96M | -14.84M | -10.46M | |||
| EBITDA | -38.29M | -29.91M | -25.06M | -15.37M | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.40 | -0.46 | -1.50 | -0.93 | -0.65 | |||
| Non GAAP EPS | -0.40 | -0.53 | -1.50 | -0.93 | N/A | |||
| Statistics | ||||||||
All data in USD